4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Eiken Chemical Co., Ltd. (4549) operates in the Medical Devices industry and is headquartered in Tokyo, Japan with about 696 employees. Its market capitalization is roughly JPY 74 billion. In the fiscal year ended 2026-03-31, 4549 reported JPY 41.9B in revenue and JPY 3.7B in net income.
Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics in Japan.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | JPY 41.9B | JPY 40.5B | JPY 40.1B | JPY 43.3B | — |
| Gross Profit | JPY 16.2B | JPY 16.5B | JPY 16.7B | JPY 20.5B | — |
| Operating Income (EBIT) | JPY 2.9B | JPY 3.0B | JPY 3.4B | JPY 7.5B | — |
| Net Income | JPY 3.7B | JPY 2.2B | JPY 2.6B | JPY 5.7B | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (JPY 1.9B) | (JPY 1.8B) | (JPY 1.9B) | (JPY 2.0B) | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | JPY 62.7B | JPY 62.4B | JPY 61.7B | JPY 66.3B | — |
| Total Liabilities | JPY 18.6B | JPY 18.8B | JPY 15.7B | JPY 16.7B | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4549 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms